Pharming Group N.V. (PHAR)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Market Capitalization	622	763	756	572	993	1,106
Market Cap Growth	-33.06%	0.93%	32.18%	-42.41%	-10.20%	105.11%
Enterprise Value	580	728	702	554	963	1,103
Last Close Price	9.10	11.43	11.03	8.94	15.20	-
PE Ratio	-	-	55.27	35.75	26.30	27.26
PS Ratio	1.99	3.11	3.68	2.88	4.68	5.84
PB Ratio	2.51	3.49	3.69	2.96	5.41	9.42
P/TBV Ratio	3.58	5.17	5.82	5.23	10.47	25.82
P/FCF Ratio	-	-	35.85	21.10	12.57	15.46
P/OCF Ratio	1379.55	-	33.65	15.11	11.87	14.91
EV/Sales Ratio	2.03	2.97	3.41	2.78	4.54	5.82
EV/EBITDA Ratio	-	-	44.16	18.22	11.66	15.23
EV/EBIT Ratio	-	-	67.70	23.07	12.62	16.36
EV/FCF Ratio	-	-	33.29	20.43	12.19	15.42
Debt / Equity Ratio	0.56	0.78	0.81	0.84	0.88	0.50
Debt / EBITDA Ratio	209.36	-	9.03	4.88	1.92	0.79
Debt / FCF Ratio	-	-	7.91	5.97	2.05	0.81
Asset Turnover	0.66	0.55	0.50	0.49	0.63	0.76
Inventory Turnover	0.52	0.51	0.50	0.87	1.26	1.35
Quick Ratio	2.76	3.28	3.90	4.69	3.08	0.90
Current Ratio	3.53	4.06	4.65	5.33	3.43	1.05
Return on Equity (ROE)	-8.18%	-4.98%	6.88%	8.50%	25.10%	43.52%
Return on Assets (ROA)	-1.38%	-3.06%	1.57%	3.68%	14.13%	17.01%
Return on Capital (ROIC)	-1.64%	-3.57%	1.78%	4.29%	18.30%	25.85%
Earnings Yield	-2.86%	-1.38%	1.81%	2.80%	3.80%	3.67%
FCF Yield	-0.08%	-2.46%	2.79%	4.74%	7.95%	6.47%
Buyback Yield / Dilution	1.41%	7.09%	-0.85%	-2.70%	-1.37%	-3.06%
Total Shareholder Return	1.41%	7.09%	-0.85%	-2.70%	-1.37%	-3.06%

Source: S&P Capital IQ. Standard template. Financial Sources.